Streetbeat News

Equity Actions

MLNK

MeridianLink, Inc. announced the resignation of Cody Cowan from its Board and Sean Blitchok as CFO, effective March 15 and April 1, 2024, respectively. Laurence E. Katz has been appointed as the new CFO and Director starting April 1, 2024. Blitchok's resignation includes a transition agreement without severance but with consulting fees through September 30, 2024. Katz brings extensive experience from previous roles at StubHub, Genesys, JPMorgan Chase & Co., and The Walt Disney Company.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 10:46 am

RITM

Rithm Capital has announced the early tender results for its cash tender offer to purchase up to $275 million of its outstanding 6.250% Senior Unsecured Notes due 2025. This move is part of Rithm Capital's financial management strategy to manage its debt obligations.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 10:44 am

WD

Walker & Dunlop has arranged a $109 million construction financing deal for a multifamily development in Brooklyn. This move signifies the company's active involvement in facilitating significant real estate projects, potentially impacting its financial performance and market perception positively.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 10:42 am

MLNK

MeridianLink announced that Sean Blitchok will resign as CFO on April 1, and Larry Katz will replace him as the new CFO and board member.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 10:32 am

SN

SharkNinja, affiliated with Xuning Wang, has initiated an underwritten public offering of 4.7 million ordinary shares. This move could potentially impact the stock's liquidity and market perception.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 10:21 am

GDTC

CytoMed Therapeutics has received board approval to start a pilot program on June 1, 2024, for isolating and cryo-storing peripheral blood mononuclear cells. This program will be offered on a complimentary basis as a reward to loyal shareholders of CytoMed.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 10:16 am

TELL

VIRT

Tellurian Inc. has entered into an agreement with Virtu Americas to sell shares worth up to $366.1 million, as announced on March 15, 2024. This strategic move could potentially provide Tellurian with significant financial flexibility and support its future growth plans.

Portfolio Pulse from Charles Gross

March 18, 2024 | 10:06 am

UXIN

Uxin has signed a term sheet with Xin Gao Group and an investment fund for financing approximately $34.8 million at a rate of $0.004858 per share, equivalent to $1.4574 per American Depositary Share (ADS). This term sheet is a commitment to negotiate in good faith towards definitive agreements for the financing.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 9:06 am

QD

Qudian's Board has approved a new share buyback program to purchase up to US$300 million worth of Class A ordinary shares or ADSs over 36 months starting June 13, 2024. This is in addition to the existing program initiated in June 2022, under which the company has already purchased 56.7 million ADSs for approximately US$94.2 million. The existing program is set to conclude on June 12, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 9:04 am

GVH

Globavend Holdings Limited (NASDAQ:GVH), an e-commerce logistics provider, has entered into a $20M equity line of credit facility with Square Gate Capital Master Fund. This agreement allows Globavend to sell up to $20M of its shares to Square Gate over the next 36 months, with the shares to be registered for public resale.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:07 am